Brainstorm Cell Therapeutics Inc. (BCLI)
Operating Income Growth
16.38%
TTM · Period ending:
BCLI Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported16.38%period ending
Latest reported16.38%period ending
BCLI TTM Operating Income YoY % (-87.38% → 16.38%)
Year-over-year change
High-resolution chart · PNG
BCLI operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 16.3795% | |
| 27.6081% | |
| 14.8807% | |
| 18.1094% | |
| 26.9776% | |
| 34.3993% | |
| 45.4592% | |
| 38.2459% | |
| 27.1113% | |
| 23.4142% | |
| 13.629% | |
| 17.493% | |
| 8.9554% | |
| -6.1209% | |
| -1.1533% | |
| 12.4053% | |
| 15.4034% | |
| 23.8245% | |
| 22.5508% | |
| -7.0357% | |
| -0.3526% | |
| -14.8743% | |
| -37.7505% | |
| -34.1068% | |
| -56.7357% | |
| -58.1216% | |
| -63.5569% | |
| -147.6514% | |
| -144.4886% | |
| -201.3728% | |
| -181.3163% | |
| -42.4834% | |
| -47.0485% | |
| -9.8195% | |
| 1.6526% | |
| -0.9777% | |
| 24.1017% | |
| 38.0941% | |
| 40.4522% | |
| 40.5405% | |
| 30.0186% | |
| 5.2589% | |
| -0.4117% | |
| -35.9728% | |
| -64.9991% | |
| -42.1131% | |
| -69.4101% | |
| -72.347% | |
| -36.8458% | |
| -66.7034% | |
| -46.4682% | |
| 2.4026% | |
| -11.0246% | |
| 18.233% | |
| 16.1527% | |
| -25.6448% | |
| -16.5709% | |
| -77.0551% | |
| -57.9436% | |
| -74.8847% | |
| -73.2321% | |
| -37.768% | |
| -47.8286% | |
| 16.3379% | |
| 21.6338% | |
| 31.9746% | |
| 46.4504% | |
| 26.8048% | |
| 38.2666% | |
| 33.9264% | |
| 23.1279% | |
| 32.4654% | |
| 4.929% | |
| 1.7723% | |
| -24.8125% | |
| -44.6361% | |
| -22.053% | |
| -24.811% | |
| -5.4347% | |
| 82.7581% | |
| 82.5276% | |
| 82.3842% | |
| 82.268% | |
| -1,059.5976% | |
| -28,619.1678% | |
| -26,312.5023% | |
| -58,288.959% | |
| -4,205.8754% | |
| -75.7749% | |
| -87.3782% |